Immunohistochemical mapping of nitric oxide synthase in the rat hypothalamus and colocalization with neuropeptides.
The localization and distribution of nitric oxide synthase in the hypothalamus have been studied with an immunohistochemical technique using antibodies to neuronal rat nitric oxide synthase. Subsequent double-labeling experiments examined the colocalization patterns of nitric oxide synthase and several peptides. Our results demonstrate a widespread occurrence of nitric oxide synthase-immunoreactive nerve cell bodies and processes throughout the hypothalamus, especially in various parts of the preoptic region, in the supraoptic and paraventricular nuclei, the lateral hypothalamic area, the ventromedial and dorsomedial nuclei, the arcuate nucleus and various parts of the mammillary region. Double labeling experiments showed that nitric oxide synthase-like immunoreactivity coexists with substance P-like immunoreactivity in the medial preoptic area, with oxytocin-, cholecystokinin-and galanin message-associated peptide-like immunoreactivity in the supraoptic nucleus, with enkephalin, oxytocin- and corticotropin releasing factor-like immunoreactivity in the paraventricular nucleus and with enkephalin-like immunoreactivity in the arcuate nucleus. Furthermore, in the ventromedial nucleus, nitric oxide synthase-like immunoreactivity coexisted with enkephalin-, substance P-, and somatostatin-like immunoreactivity, and in the dorsomedial nucleus with enkephalin-, galanin message-associated peptide-and substance P-like immunoreactivity. In the mammillary region nitric oxide synthase-like immunoreactivity coexisted with enkephalin-, cholecystokinin-, and substance P-like immunoreactivity. Among these neuropeptides, enkephalin and substance P were most frequently found in nitric oxide synthase-immunoreactive neurons. We conclude that nitric oxide synthase-immunoreactive neurons contain neuropeptides in various parts of the hypothalamus, and that nitric oxide in the hypothalamus may be involved in a variety of neuroendocrine and autonomic functions.
Yamada
K
K
Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
Emson
P
P
Hökfelt
T
T
D000818:Animals; D000918:Antibody Specificity; D001931:Brain Mapping; D002766:Cholecystokinin / Q000032:analysis / Q000276:immunology; D003346:Corticotropin-Releasing Hormone / Q000032:analysis / Q000276:immunology; D004745:Enkephalins / Q000032:analysis / Q000276:immunology; D005609:Free Radicals; D019004:Galanin / Q000032:analysis / Q000276:immunology; D007034:Hypothalamus, Posterior / Q000737:chemistry / Q000201:enzymology*; D007150:Immunohistochemistry; D008297:Male; D008326:Mammillary Bodies / Q000737:chemistry / Q000201:enzymology; D009479:Neuropeptides / Q000032:analysis* / Q000276:immunology; D019001:Nitric Oxide Synthase / Q000032:analysis* / Q000276:immunology; D010121:Oxytocin / Q000032:analysis / Q000276:immunology; D010446:Peptide Fragments / Q000032:analysis / Q000276:immunology; D011301:Preoptic Area / Q000737:chemistry / Q000201:enzymology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013004:Somatostatin / Q000032:analysis / Q000276:immunology; D013373:Substance P / Q000032:analysis / Q000276:immunology
D004745:Enkephalins; D005609:Free Radicals; D009479:Neuropeptides; D010446:Peptide Fragments; C078371:galanin message-associated peptide; D013373:Substance P; D010121:Oxytocin; D013004:Somatostatin; D019004:Galanin; D002766:Cholecystokinin; D003346:Corticotropin-Releasing Hormone; D019001:Nitric Oxide Synthase